Halozyme Therapeutics, Inc.
-
Ticker
HALO
-
Industry
Biotechnology More
-
Sector
Healthcare More
- 201-500 Employees
- Based in San Diego, California
Halozyme Therapeutics is a biopharmaceutical company developing and commercializing products targeting the extracellular matrix for the endocrinology, oncology, dermatology and drug delivery markets. The company's product portfolio is primarily based on intellectual property covering the family of human enzymes known as hyaluronidases and additional enzymes that affect the extracellular matrix.
REPORT RATINGS
5.0 / 5.0 (1)
Halozyme Therapeutics, Inc. reports have an aggregate usefulness score of 5.0 based on 1 reviews.
Halozyme Therapeutics, Inc.
Most Recent Responsibility Report
MOST RECENT
2023 Environmental, Social & Governance Report
Archived Responsibility Reports
Our service enables potential investors to review the most recent and archived Halozyme Therapeutics, Inc. Sustainability Report, Halozyme Therapeutics, Inc. Corporate Social Responsibility Report, Halozyme Therapeutics, Inc. CSR Report, Halozyme Therapeutics, Inc. Corporate Responsibility, Halozyme Therapeutics, Inc. CR Report, Halozyme Therapeutics, Inc. Citizenship Report, Halozyme Therapeutics, Inc. ESG Report, and Halozyme Therapeutics, Inc. Environmental Report online.